glp-1/gip agonist Free Comparison Chart: GLP-1 and GIP/GLP-1 Receptor Agonists for Type 2 Diabetes π Link in bio #FOAMed #Type2Diabetes #GLP1 Mechanisms of action and therapeutic
Description
52,53 The improvement of antioxidant stress through GLP-1 signaling seems to be related to the activation of the GLP-1 R/cAMP/PKA signaling pathway and nuclear factor erythroid 2-related factor 2/heme oxygenase 1 signaling pathway

45,46 In contrast, anorexigenic neurons suppress appetite by expressing proopiomelanocortin (POMC) and cocaine- and amphetamine-regulated transcript (CART) peptide

Most patients tolerate this without symptoms, but those with underlying arrhythmias or cardiovascular disease should be monitored

Calorie needs should be individualized based on sex, size, and activity level, with most adults avoiding intake below 1000-1200 calories daily without medical supervision

These are typically mild and resolve without intervention

In the same trial, tirzepatide and semaglutide were compared once weekly in the open-label, phase III SURPASS-2 experiment
